Autopsy report · NCT04373603

Use of Tranexamic Acid in Facial Fillers

“Study closed prior to opening to enrollment, due to funding availability for study”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 4

Sponsor

University of Wisconsin, Madison

Sponsor type

University, hospital or other

Conditions

Injection Site Bruising

Interventions

Tranexamic acid; Saline; Hyaluronic acid

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Reconstruction Flaps for Nasal Surgical Wounds RCT
  “Study closed before enrollment could begin.” (85% match in meaning)
• Characterization of the Pathogenesis of Primary and Secondary Lymphatic Disorders
  “Study closed before total enrollment met.” (84% match in meaning)
• Ruxolitinib for Early Lung Dysfunction After Hematopoietic Stem Cell Transplant
  “Study closed due to slow enrollment.” (81% match in meaning)
• A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer
  “Study closed to enrollment due to low accrual.” (81% match in meaning)
• Adipose Derived SVF for Aero-digestive & Enterocutaneous Fistulae
  “Study closed due to lack of patient enrollment.” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.